PulmoBioMed wins national life science competition
Healthcare marketing communications agency, Onyx Health, has chosen innovative MedTech spinout PulmoBioMed as the winner of its £5,000 #ThinkBig competition, designed to help life science companies bounce back from the COVID-19 crisis.
Having been chosen as the lucky winner of the competition, PulmoBioMed will receive £5,000 of Onyx Health's full range of specialist healthcare communications support for free, helping them achieve commercial success and access key target markets. #ThinkBig is aimed at innovative start-ups and SMEs in the health and life science sectors, who are at the cutting edge of the industry and can bring something distinctive to the market.
PulmoBioMed is a newly-launched Northumbria University spin-out, founded by Associate Professor Dr Sterghios Moschos and supported into commercialisation by Chief Executive Officer Dr Pete Hotten, who has over 20 years of senior management experience.
Dr Moschos' pioneering work in biomedical sciences and proof of concept funding from Northern Accelerator has led to the creation of an innovative, hand-held breath testing device PBM-Hale™. The device allows sampling of the lungs in a non-invasive way, which can be used to detect biomarkers in the breath, for lung conditions such as COVID-19, therapeutic drugs and substances of abuse. This potentially ground-breaking technology is currently being trialled in clinical centres across Europe, with exciting results expected soon.
Onyx Health Associate Director, Louise Flintoft, said: "We had a strong field of entries from across the UK and Europe for our #ThinkBig competition, and from diverse areas of medical diagnostics and devices, biotechnology and digital therapeutics. PulmoBioMed is a spin-out with commercial potential and a wide range of diagnostic applications. They are a great fit with Onyx Health's ethos and values as an agency and we feel we can offer them the greatest value from the £5,000 prize."
PulmoBioMed Chief Operating Officer, Jonathan Brookes, added: "We've already had a flurry of interest in PBM-Hale™ and its range of clinical applications following our recent launch. We've gained recognition as a leading company in our field. Our key focus is on developing and commercialising the breath sampling technology and its integration into a range of healthcare settings. Onyx Health's specialist healthcare communication knowledge will help us stand out from the crowd in a highly competitive market".
The Go Further Investment Index is an opportunity to engage, showcase and celebrate progressive businesses who are pushing through and achieving their aspirations through access to investment, impactful collaborations, and the foresight to inform and respond to the changing world around them.
It is open to Northern Powerhouse and Scotland-based businesses of all sizes and from all sectors, but we are particularly interested in businesses operating within bio-science, health tech, clean energy, decarbonisation, circular economy, data and digitisation, space and satellite, tech, AI and advanced manufacturing.
For more info visit www.gofurtherindex.co.uk.